Jaya Konstruksi Manggala Pratama Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Jaya Konstruksi Manggala Pratama Tbk trades at Rp69 (market cap 1.09T, 1.3M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Jaya Konstruksi Manggala Pratama Tbk is far larger — about 6.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Jaya Konstruksi Manggala Pratama Tbk is more actively traded (1.3M versus 96.7K). Which is the better fit depends on your goals.
| JKON | OBAT | |
|---|---|---|
Market Cap | 1.09T | 167.37B |
Volume | 1.3M | 96.7K |
Lot | 13.01K | 967 |
Turnover | 88.78M | 23.82M |
Average Price | 68.24 | 246.34 |
Value | 88.78M | 23.82M |
Indicative Equilibrium Price | 69 | 248 |
Indicative Equilibrium Volume | 1.9K | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Jaya Konstruksi Manggala Pratama Tbk (the company) was established dated December 23, 1982 based on Notaries Deed No.45 of Hobropoerwanto, SH. The Company’s articles of association has been amended several times, most recently by notarial deed No. 142 of Mr. Aulia Taufani, SH., dated Sep 24, 2007, concerning among others, the change Company’s capital structure and public offering.
Read more on JKON →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →